Literature DB >> 23788760

Inducible ApoE gene repair in hypomorphic ApoE mice deficient in the low-density lipoprotein receptor promotes atheroma stabilization with a human-like lipoprotein profile.

Delphine Eberlé1, Fu Sang Luk, Roy Y Kim, Victor R Olivas, Nikit Kumar, Jessica M Posada, Kang Li, Nathalie Gaudreault, Joseph H Rapp, Robert L Raffai.   

Abstract

OBJECTIVE: To study atherosclerosis regression in mice after plasma lipid reduction to moderately elevated apolipoprotein B (apoB)-lipoprotein levels. APPROACH AND
RESULTS: Chow-fed hypomorphic Apoe mice deficient in low-density lipoprotein receptor expression (Apoe(h/h)Ldlr(-/-)Mx1-cre mice) develop hyperlipidemia and atherosclerosis. These mice were studied before and after inducible cre-mediated Apoe gene repair. By 1 week, induced mice displayed a 2-fold reduction in plasma cholesterol and triglyceride levels and a decrease in the non-high-density lipoprotein:high-density lipoprotein-cholesterol ratio from 87%:13% to 60%:40%. This halted atherosclerotic lesion growth and promoted macrophage loss and accumulation of thick collagen fibers for up to 8 weeks. Concomitantly, blood Ly-6C(high) monocytes were decreased by 2-fold but lesional macrophage apoptosis was unchanged. The expression of several genes involved in extracellular matrix remodeling and cell migration was changed in lesional macrophages 1 week after Apoe gene repair. However, mRNA levels of numerous genes involved in cholesterol efflux and inflammation were not significantly changed at this time point.
CONCLUSIONS: Restoring apoE expression in Apoe(h/h)Ldlr(-/-)Mx1-cre mice resulted in lesion stabilization in the context of a human-like ratio of non-high-density lipoprotein:high-density lipoprotein-cholesterol. Our data suggest that macrophage loss derived in part from reduced blood Ly-6C(high) monocytes levels and genetic reprogramming of lesional macrophages.

Entities:  

Keywords:  apolipoprotein E; atherosclerosis; macrophage; monocyte

Mesh:

Substances:

Year:  2013        PMID: 23788760      PMCID: PMC3811094          DOI: 10.1161/ATVBAHA.112.300605

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  34 in total

1.  Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E.

Authors:  R K Tangirala; D Praticó; G A FitzGerald; S Chun; K Tsukamoto; C Maugeais; D C Usher; E Puré; D J Rader
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

2.  HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells.

Authors:  Jonathan E Feig; James X Rong; Raanan Shamir; Marie Sanson; Yuliya Vengrenyuk; Jianhua Liu; Katey Rayner; Kathryn Moore; Michael Garabedian; Edward A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

3.  ApoE suppresses atherosclerosis by reducing lipid accumulation in circulating monocytes and the expression of inflammatory molecules on monocytes and vascular endothelium.

Authors:  Nathalie Gaudreault; Nikit Kumar; Jessica M Posada; Kyle B Stephens; Nabora Soledad Reyes de Mochel; Delphine Eberlé; Victor R Olivas; Roy Y Kim; Matthew J Harms; Sean Johnson; Louis M Messina; Joseph H Rapp; Robert L Raffai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-03       Impact factor: 8.311

4.  Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice.

Authors:  R K Tangirala; K Tsukamoto; S H Chun; D Usher; E Puré; D J Rader
Journal:  Circulation       Date:  1999-10-26       Impact factor: 29.690

5.  Stage-specific remodeling of atherosclerotic lesions upon cholesterol lowering in LDL receptor knockout mice.

Authors:  Ying Zhao; Dan Ye; Jun Wang; Laura Calpe-Berdiel; Saaleha B R N Azzis; Theo J C Van Berkel; Miranda Van Eck
Journal:  Am J Pathol       Date:  2011-07-08       Impact factor: 4.307

6.  ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice.

Authors:  Andrew J Murphy; Mani Akhtari; Sonia Tolani; Tamara Pagler; Nora Bijl; Chao-Ling Kuo; Mi Wang; Marie Sanson; Sandra Abramowicz; Carrie Welch; Andrea E Bochem; Jan Albert Kuivenhoven; Laurent Yvan-Charvet; Alan R Tall
Journal:  J Clin Invest       Date:  2011-10       Impact factor: 14.808

7.  Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model.

Authors:  E D Reis; J Li; Z A Fayad; J X Rong; D Hansoty; J G Aguinaldo; J T Fallon; E A Fisher
Journal:  J Vasc Surg       Date:  2001-09       Impact factor: 4.268

8.  Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression.

Authors:  Stephane Potteaux; Emmanuel L Gautier; Susan B Hutchison; Nico van Rooijen; Daniel J Rader; Michael J Thomas; Mary G Sorci-Thomas; Gwendalyn J Randolph
Journal:  J Clin Invest       Date:  2011-04-18       Impact factor: 14.808

9.  Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content.

Authors:  J X Rong; J Li; E D Reis; R P Choudhury; H M Dansky; V I Elmalem; J T Fallon; J L Breslow; E A Fisher
Journal:  Circulation       Date:  2001-11-13       Impact factor: 29.690

10.  Monocyte-to-macrophage differentiation: synthesis and secretion of a complex extracellular matrix.

Authors:  Mary Y Chang; Christina K Chan; Kathleen R Braun; Pattie S Green; Kevin D O'Brien; Alan Chait; Anthony J Day; Thomas N Wight
Journal:  J Biol Chem       Date:  2012-02-20       Impact factor: 5.157

View more
  8 in total

Review 1.  Dyslipidaemia in 2013: New statin guidelines and promising novel therapeutics.

Authors:  Dimitri P Mikhailidis; Vasilios G Athyros
Journal:  Nat Rev Cardiol       Date:  2013-12-24       Impact factor: 32.419

Review 2.  Mechanisms that regulate macrophage burden in atherosclerosis.

Authors:  Gwendalyn J Randolph
Journal:  Circ Res       Date:  2014-05-23       Impact factor: 17.367

3.  The immunosuppressant FTY720 prolongs survival in a mouse model of diet-induced coronary atherosclerosis and myocardial infarction.

Authors:  Guanying Wang; Roy Y Kim; Isabella Imhof; Norman Honbo; Fu Sang Luk; Kang Li; Nikit Kumar; Bo-Qing Zhu; Delphine Eberlé; Daniel Ching; Joel S Karliner; Robert L Raffai
Journal:  J Cardiovasc Pharmacol       Date:  2014-02       Impact factor: 3.105

4.  ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  J Lipid Res       Date:  2016-03-25       Impact factor: 5.922

5.  An intracellular matrix metalloproteinase-2 isoform induces tubular regulated necrosis: implications for acute kidney injury.

Authors:  Carla S Ceron; Celine Baligand; Sunil Joshi; Shaynah Wanga; Patrick M Cowley; Joy P Walker; Sang Heon Song; Rajeev Mahimkar; Anthony J Baker; Robert L Raffai; Zhen J Wang; David H Lovett
Journal:  Am J Physiol Renal Physiol       Date:  2017-03-22

6.  Immunosuppression With FTY720 Reverses Cardiac Dysfunction in Hypomorphic ApoE Mice Deficient in SR-BI Expression That Survive Myocardial Infarction Caused by Coronary Atherosclerosis.

Authors:  Fu Sang Luk; Roy Y Kim; Kang Li; Daniel Ching; David K Wong; Sunil K Joshi; Isabella Imhof; Norman Honbo; Holly Hoover; Bo-Qing Zhu; David H Lovett; Joel S Karliner; Robert L Raffai
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

7.  Isolation of Plasma Lipoproteins as a Source of Extracellular RNA.

Authors:  Kang Li; David K Wong; Fu Sang Luk; Roy Y Kim; Robert L Raffai
Journal:  Methods Mol Biol       Date:  2018

Review 8.  Apolipoprotein E and Atherosclerosis: From Lipoprotein Metabolism to MicroRNA Control of Inflammation.

Authors:  Laura Bouchareychas; Robert L Raffai
Journal:  J Cardiovasc Dev Dis       Date:  2018-05-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.